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Abstract
Mucus overproduction is a major contributor to morbidity and
mortality in asthma. Mucus overproduction is induced by
orchestrated actions of multiple factors that include inflammatory
cytokines andg-aminobutyric acid (GABA). GABA is produced only
by pulmonary neuroendocrine cells (PNECs) in the mouse lung.
Recent studies in a neonatal mouse model of allergic inflammation
have shown that PNECs play an essential role in mucus
overproduction by GABA hypersecretion. Whether PNECs mediate
dysregulatedGABA signaling formucus overproduction in asthma is
unknown. In this study,we characterized the cellular source ofGABA
in the lungs of nonhuman primates and humans and assessed GABA
secretion and signaling in primate diseasemodels.We found that like
in mice, PNECs were the major source of GABA in primate lungs. In
addition, an infant nonhuman primatemodel of asthma exhibited an
increase in GABA secretion. Furthermore, subjects with asthma had
elevated levels of expression of a subset of GABA type a (GABAa)
and type b (GABAb) receptors in airway epithelium compared with
those of healthy control subjects. Last, employing a normal human
bronchial epithelial cell model of preinducedmucus overproduction,
we showed pharmaceutical blockade of GABAa and GABAb
receptor signaling reversed the effect of IL-13 onMUC5AC gene
expression and goblet cell proliferation. Together, our data
demonstrate an evolutionarily conserved intraepithelial GABA
signaling that, in concert with IL-13, plays an essential role in mucus
overproduction. Our findings may offer new strategies to ameliorate
mucus overproduction in patients with asthma by targeting PNEC
secretion and GABA signaling.
Keywords: pulmonary neuroendocrine cell; g-aminobutyric acid;
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Mucus overproduction is a salient clinical
feature of chronic airway diseases such as
asthma and chronic obstructive pulmonary
disease (COPD) (1). A major cell type in the
airway epithelium that produces mucin is
goblet cells. Patients with asthma and
COPD have an increased number of
goblet cells and mucus hypersecretion.
Goblet cell hyperplasia is known to be
triggered by inflammation in response to
damaging exposures to environmental
insults, such as allergen, ozone (O3),
respiratory virus, and cigarette smoke.
Excessive mucus in the airway blocks
airflow, which causes disease exacerbation
and contributes to disease mortality. To
date, there is no drug that directly targets
mucus overproduction.
Asthma often starts in early childhood.
Both clinical and epidemiological findings
reveal the association between early-life
exposure to environmental insults and
wheezing and asthma in young children
(2, 3). Previous studies using rodent and
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nonhuman primate models indicated that
the detrimental exposure in early life may
cause long-term changes in lung structure
and function, thereby contributing to
the pathophysiology of asthma (4–6).
Consistent with this hypothesis, the
nervous system has been shown to undergo
aberrant changes after early-life exposure
(4, 5, 7–9) at least in part through the cross-
talk between inflammation and the nerves
(10). The nervous system in the lung is
known to innervate airway smooth muscle
cells and pulmonary neuroendocrine cells
(PNECs). Genetic studies in the neonatal
mouse models of allergen exposure have
shown that changes in lung innervation
alter the contractile phenotype of airway
smooth muscle and induce the aberrant
secretion from PNECs (4, 11, 12). Notably,
PNECs express a variety of neuropeptides
and bioactive amines that include
g-aminobutyric acid (GABA) and
calcitonin-related gene peptide. GABA,
which is produced only by PNECs and
secreted through the regulation of nerves in
the mouse lung, is essential for mucus
overproduction (12–14). Whether PNEC
innervation and secretion are altered after
damaging exposures in early life in asthma
is unknown.
In contrast to nonhuman primate
and human lungs that normally have a
significant number of goblet cells, the mouse
lung has few goblet cells at baseline (1).
After exposure to environmental insults in
mice, secretory cells transdifferentiate into
goblet cells through a process known as
mucus metaplasia (15–17). However,
despite the difference in the cell origin of
goblet cells between mice and primates,
mechanisms underlying mucus
overproduction are conserved. The
overproduction of mucus in patients with
asthma and animal models is driven
by inflammatory cytokines, including
IL-13. In addition, several transcriptional
factors that are essential for mucus
overproduction in animal models of
asthma, such as SPDEF (SAM pointed
domain-containing Ets transcription
factor) and FOXA3, have been shown to
be upregulated in the airway epithelium of
patients with asthma (17, 18). Furthermore,
GABA has been shown to play an essential
role in allergen- and nicotine-induced
mucus overproduction (19, 20). GABA has
two types of receptors: GABAa and
GABAb receptors. The GABAa receptor
consists of five subunits and functions as a
ligand-gated Cl2 channel, whereas the
GABAb receptor consists of GABBR1 and
GABBR2 and is a G protein–coupled
receptor. Allergen exposure causes an
increase in the expression of GABAa
receptor subunits in airway epithelium of
both mice and humans (19). Prenatal
exposure to cigarette smoke in nonhuman
primates has been shown to induce
GABA production and GABAa receptor
expression (21). Functional studies in mice
have demonstrated that although GABA
alone has no effect on the amount of
mucus production, dysregulated GABA
signaling is essential for IL-13–induced
mucus overproduction in airway
epithelium (12, 14). In addition, in a
culture model of nonhuman primate
airway epithelial cells, nicotine-induced
mucus overproduction requires GABAa
receptor signaling (20). So far, the role
of the GABAb receptor in mucus
overproduction is unknown. More
important, whether GABA signaling may
serve as a drug target to reduce already-
established mucus overproduction under
the diseased condition has never been
tested.
Building on previous findings in mice
that the nerve–PNEC–GABA axis was
required for mucus overproduction after
early-life allergen exposure (12), we sought
to test whether this axis plays an
evolutionarily conserved role in asthma by
employing the infant nonhuman primate
model of environmental insults and a
normal human bronchial epithelial (NHBE)
cell culture model of prestimulated mucus
overproduction. By characterizing GABA
and GABA receptor expression in vivo and
functional studies of the GABAa and
GABAb receptors in vitro, we provide
evidence in support of an essential role of
GABA secreted from PNECs in mucus
overproduction in primate models of
asthma.
Methods
Human Cell/Tissue Study Approval
NHBE cells were obtained by the Tissue
Procurement and Cell Culture Core at the
University of North Carolina, Chapel Hill
(institutional review board–approved
protocol no. 03-1396). Human lungs from
de-identified organ donors with no
preexisting lung disease were procured
from the International Institute for the
Advancement of Medicine. This study used
three adult donor lungs. Because the study
did not involve the collection of data
through an intervention or interaction
with individual subjects or identifiable
private information about living
individuals, the study was deemed
nonhuman research by the Partners
Human Research Committee.
Nonhuman Primate Model of O3 and
House Dust Mite Allergen Exposure
Infant rhesus monkeys were subjected to 11
episodes of exposure to O3 and house dust
mite allergen (HDMA) starting around
Postnatal Day 30 (22). Monkeys were
killed at 6 months of age. All exposure
experiments in nonhuman primates were
performed at the California National
Primate Research Center at the University
of California, Davis (www.cnprc.ucdavis.
edu/ourscience/respiratory-diseases/),
under an animal protocol approved by
the institutional animal care and use
committee. Archived tissue blocks and
serum samples were used for this study.
GABA Receptor Expression in Airway
Brushing Samples of Healthy Donors
and Donors with Asthma
Microarray datasets GOBMUC2A (patients
with asthma; n = 7) and GOBMUC2H
(healthy; n = 11) were downloaded from the
Gene Expression Omnibus (GEO) website
(www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
andacc=GSe4302) (23). The Affymetrix
CEL files are robust multiarray average
normalized via the R/Bioconductor affy
package. For the resulting data matrix of
probes/genes, for each probe of GABA-
related genes of interest, Wilcoxon’s rank-
sum test was applied to assess the difference
in median signal between the patients with
asthma and healthy donor population. Any
differences with P value less than 0.05 were
deemed significant. To account for multiple
hypothesis testing, we computed the
corresponding positive false discovery rate
analog of the P value called a q value for the
21 tested GABA receptor genes using the
MATLAB (MathWorks) function mafdr
(24).
Air–Liquid Interface Culture of
NHBE Cells
NHBE cells (25) were expanded and
cultured at an air–liquid interface (ALI)
using an established protocol (26). To
induce goblet cell hyperplasia, the ALI
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culture was treated with human IL-13 (10
ng/ml, catalogue no. 200-13; PeproTech)
starting from Day 0 of ALI. The ALI culture
was treated with the antagonists of the
GABAa receptor (picrotoxin, 50 mM,
catalogue no. P1675; MilliporeSigma) and
the GABAb receptor (CGP55845, 1 mM,
catalogue no. SML0594; MilliporeSigma)
starting at Day 14 of ALI. The culture
medium was changed every other day. The
ALI culture was analyzed at Day 21.
Statistical Analyses
Data represented mean6 SEM from at
least three independent experiments. For
comparisons between two conditions,
statistical analysis was performed using
unpaired Student’s t test. For the
assessment of the effect of GABA receptor
inhibitors in control and IL-13–treated
conditions, statistical analysis was
performed with one-way ANOVA followed
by Tukey’s post hoc test for multiple
comparisons. The difference between
experimental groups was considered
statistically significant if the P value was less
than 0.05. Details of antibodies,
immunohistochemistry, the ALI culture,
and quantitative PCR are provided in the
data supplement.
Results
Expression of GABA and GABA
Receptors in the Lung of Nonhuman
Primates and Humans
PNECs have been shown to be the only
source of GABA in the mouse lung through
the activity of biosynthetic enzyme glutamate
decarboxylase 67 (GAD67) by a GAD67-GFP
report mouse line and immunostaining
using a monoclonal antibody (12, 13). No
GAD65 expression in the mouse lung was
found (12). However, a previous study
suggested ubiquitous GAD65/67 expression
in airway epithelium by immunostaining
using a polyclonal GAD65/67 antibody (19).
We suspected that the discrepancy may
be caused by limited specificity of the
polyclonal antibody. To resolve the issue of
GABA production in the primate lung, we
stained histological sections from rhesus
monkeys and humans with the specific
mouse monoclonal antibody against GAD67
(12). We detected GAD67 in clusters and
singular cells in airway epithelium that
coexpressed PNEC markers, such as PGP9.5
(protein gene product 9.5) in nonhuman
primates and bombesin in humans
(Figure 1A), and thus were PNECs. Notably,
all PNECs expressed GAD67 in mice and in
nonhuman primates (Figure 1A) (12, 13).
We also did not find any change in PNEC
expression of GAD67 after O3 and HDMA
exposure, which is consistent with our
findings in the mouse model of allergen
exposure (12). However, in human donor
lungs, approximately 80% of PNECs were
labeled by the GAD67 antibody (Figure 1A).
This finding indicates the heterogeneity
of the PNEC population in humans.
Although the antibody staining may exclude
cells with low levels of GAD67 expression,
we conclude that PNECs are the major
source, if not the sole source, of GABA in
the lung of nonhuman primates and
humans.








































Figure 1. Airway epithelial production of g-aminobutyric acid (GABA) in primate lungs and GABA receptors in healthy humans and humans with asthma.
(A) Representative glutamate decarboxylase 67 (GAD67) expression in pulmonary neuroendocrine cells (PNECs). Histological sections of the lung in
rhesus monkeys (6 mo old) and infant human donors were double stained for GAD67 and PNEC markers PGP9.5 (protein gene product 9.5) and
bombesin, respectively. *Bombesin1 PNECs that are GAD672. Arrows mark nonspecific labeling by the GAD67 antibody in human lung mesenchyme. For
quantification, 10 tissue sections from six monkeys were stained, and a total of 129 PNECs were all found to express GAD67. For the human lung, five
tissue sections from three donor lungs were stained. Of 74 bombesin1 PNECs, 58 were GAD671. Scale bars: 25 mm. (B) Relative GABA receptor gene
expression in airway epithelium of healthy donors (n = 11) and donors with asthma (n = 7). Data were collected from microarray results of airway epithelial
brushing samples deposited in the Gene Expression Omnibus GSE4302 public dataset (contact contributor, P. G. Woodruff). Each column represents one
donor. *Genes with statistically significant increases in expression in asthmatic samples.
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Exposure to allergen and nicotine has
been shown to increase the expression of
several GABAa receptor subunits in airway
epithelium (19, 20). However, whether the
expression of GABAa and GABAb
receptors is altered in patients with asthma
is unknown. To evaluate the change in
GABA receptor expression in asthma, we
compared the relative gene expression
levels of GABA receptor subunits in airway
epithelial brushing samples collected
from healthy donors and donors with
asthma using published microarray
datasets deposited at the GEO website
(www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
andacc=GSe4302) (23). Of the 21 GABA
receptor genes, two GABAa receptor genes
(GABRA1 and GABRG3) and one GABAb
receptor gene (GABBR2) exhibited an
elevated level of expression in patients with
asthma compared with healthy donors. No
GABA receptor genes were downregulated
in asthma. Notably, GABRA1 and GABRG3
were not among the upregulated GABAa
receptor genes previously identified in
allergen and nicotine exposure models (19,
20). However, both previous studies and
our work uniformly identified an increase
in GABAa receptor expression. Together,
our findings support dysregulated GABAa
signaling in the asthmatic airway
epithelium. In addition, the observed
increase in GABBR2 expression in patients
with asthma suggests an additional role
of the GABAb receptor in mucus
overproduction.
Aberrant GABA Secretion and PNEC
Hyperinnervation in an Infant
Nonhuman Primate Model of
Childhood Asthma
We showed previously in a neonatal
mouse model that GABA secretion from
PNECs was induced by a hyperactivated
neurocircuitry after allergen exposure
(12). Whether early-life exposure to
environmental insults causes a similar
increase in PNEC innervation and GABA
hypersecretion, thereby contributing to
mucus overproduction in childhood
asthma, is completely unknown. This is due
to technical difficulties of obtaining the
lung tissue from young children. To
circumvent this technical issue, we took
advantage of an infant nonhuman primate
model of O3 and HDMA exposure that has
been established at the California National
Primate Research Center at the University
of California, Davis (Figure 2A) (7, 22).
Rhesus monkeys that are exposed to O3 and
HDMA during the first 6 months after birth
have been shown to present clinical
hallmarks of asthma and recapitulate
disease progression (7, 22). To assess PNEC
innervation in infant rhesus monkeys after
the exposure, tissue sections (25 mm in
thickness) were double stained for specific
markers of nerves and PNECs using a TuJ1
antibody and an antibody against PGP9.5,
respectively. Nerves surrounding PNECs
were visualized by confocal microscopy
(Figure 2B). The nerve density was
measured by normalizing TuJ1-
immunoreactive area to the number of
PNECs using Z-stacked confocal images.
Compared with control animals that were
exposed to filtered air, O3 and HDMA
exposure significantly increased the
nerve density surrounding PNECs by
approximately fourfold (Figures 2B and 2C).
We then measured GABA secretion from
PNECs by ELISA using serum samples
because PNECs are known to secrete
basolaterally into the circulation (27).
Owing to limited serum samples from the
combined O31HDMA exposure group, we
pooled all serum samples from rhesus
monkeys that were subjected to single
and combined exposures. The serum
concentration of GABA from infant
rhesus monkeys that were exposed to
environmental insults was significantly
higher than that in control animals
(Figure 2D). Therefore, environmental
exposures in infant nonhuman primates
cause aberrant increases in PNEC innervation
with associated GABA hypersecretion, which
is similar to the neonatal mouse model of
allergen exposure (12).
GABAa and GABAb Receptor
Signaling in IL-13–induced Mucus
Overproduction in ALI Culture of
NHBE Cells
Previous studies in rodent and nonhuman
primate models identified an essential role
of GABA in the induction of mucus
overproduction after allergen and nicotine
exposure (19, 20). On the basis of our
findings of the upregulation of GABA
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Figure 2. PNEC hyperinnervation and GABA hypersecretion in a nonhuman primate model of early-
life exposure. (A) Experimental scheme of rhesus monkey ozone (O3) and house dust mite allergen
(HDMA) exposure during the first 6 months after birth. Control animals were exposed to filtered air
(FA). Lungs and serum samples were harvested at 6 months of age. (B) Representative Z-stack
confocal images of PNEC innervation in 6-month-old rhesus monkeys with and without O31HDMA
exposure. PNEC innervation was assessed by double staining of proximal lung sections (25 mm in
thickness) for PGP9.5 and neuron-specific b-tubulin III using a TuJ1 antibody. Arrows mark PNECs.
Scale bar: 50 mm. (C) Quantification of PNEC innervation in infant rhesus monkeys with and without
O3 and HDMA exposure. The density of nerves surrounding PNECs was calculated by normalizing
TuJ1-immunoreactive area to the number of PNECs. At least five single PNECs and PNEC clusters
from three lungs in each group were measured. (D) Serum concentrations of GABA in control animals
(n = 7) and rhesus monkeys (n = 10) that were exposed to O3, HDMA, and combined O31HDMA.
Data presented in C and D represent mean6 SEM. *P, 0.05.
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brushing samples, we speculated that
GABAa and GABAb receptors may play
an additional role in the maintenance
and/or progression of mucus
overproduction in asthma. To test this
hypothesis, we employed an ALI culture of
NHBE cells that was prestimulated with
IL-13. The ALI culture contains multiple
epithelial cells types during differentiation
and thus provides an in vitro model for
IL-13–induced goblet cell hyperplasia and
mucus overproduction (25). Because previous
studies focused on GABAa receptors (19,
20), we chose to validate GABBR2 expression
in ALI culture at Day 14, when all
differentiated cell types were readily
identifiable (26, 28). Double staining for
GABBR2 and MUC5AC showed a mostly
apical distribution of GABBR2 in MUC5AC1
goblet cells and other epithelial cell types
(Figure 3A). Quantification of the GABBR21
and MUC5AC1 cells in three independent
ALI cultures showed that approximately
40% of MUC5AC1 goblet cells expressed
GABBR2 and that 17% of GABBR21 cells
were MUC5AC1 goblet cells.
After validating the expression of
GABA receptors in NHBE cells, we
evaluated the presence of GABA in the ALI
culture system. We detected GABA in the
culture medium itself at concentrations
within the 1–3 mM range, possibly due
to the bovine pituitary extract as a
supplement. Because only very few PNECs
formed in the ALI culture (29), PNECs are
unlikely to have contributed to the GABA
concentration in culture. Therefore, the ALI
culture contains endogenous GABA in
abundance. This finding may explain why
IL-13 is sufficient to induce goblet cell
hyperplasia in the ALI culture without the
addition of exogenous GABA.
For our assay, NHBE cells were
prestimulated with IL-13 for the first
2 weeks of the ALI culture, which has
been shown to robustly induce mucus
overproduction (30, 31). The ALI culture
was then treated for 1 week with specific
pharmaceutical blockers of GABAa and
GABAb receptors (picrotoxin and
CGP55845, respectively) at the continuous
presence of IL-13 (Figure 3B). The ALI
culture was analyzed at Day 21. Compared
with untreated control cultures, IL-13
significantly impaired ciliated cell
differentiation as shown by a decrease in
mRNA expression of FOXJ1 (a ciliated cell
marker) (Figure 3C). These findings are
consistent with a previous report that
IL-13–mediated STAT6 (signal transducer
and activator of transcription 6) signaling
represses FOXJ1 expression in the ALI
culture (32). In contrast, IL-13 had no effect
on the differentiation of secretory cells
assayed by CC10 mRNA concentrations
(Figure 3D). Furthermore, GABAa and
GABAb receptor blockers had no effect on
the differentiation of ciliated and secretory
cells in ALI culture of NHBE cells at
baseline and at the presence of IL-13
(Figures 3C and 3D).
We then assessed the effect of
GABA receptor blockers on goblet
cell differentiation and proliferation.
Approximately 10% of NHBE cells in Day
21 ALI culture were goblet cells at baseline,
as shown by their expression of MUC5AC
(Figures 4A and 4E). Treatment of ALI
cultures with GABAa and GABAb receptor
blockers had no effect on the baseline level
of MUC5AC gene expression and the
number of MUC5AC1 goblet cells (Figures
4A, 4B, and 4E). The mRNA expression
of other transcriptional factors known to
treatments +IL-13



































































Figure 3. GABAa and GABAb signaling has no effect on baseline and IL-13–induced differentiation of air–liquid interface (hALI) cultures of normal human
bronchial epithelial (NHBE) cells. (A) GABAb receptor (GABBR2) expression in ALI cultures at Day 14 of differentiation by double staining for GABBR2 and
MUC5AC. Nuclei were stained by DAPI. Arrows mark GABBR2 expression in MUC5AC1 goblet cells and other epithelial cell types. Scale bar: 50 mm.
(B) Scheme of the treatment with GABA receptor blockers in control and IL-13–stimulated ALI cultures. IL-13 (10 ng/ml) stimulation started at Day 0.
Treatment with single and combined GABAa receptor blocker (50 mM picrotoxin) and GABAb receptor blocker (1 mMCGP55845) started at Day 14. (C and D)
Cultures were analyzed at Day 21 for the gene expression of a ciliated cell marker (FOXJ1) (C) and a club cell marker (CC10) (D). Data represent mean6 SEM
of three independent experiments of NHBE cells from each donor and a total of three donors for each condition. ***P, 0.001. n.s. = not significant.
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be essential for mucus overproduction,
such as SPDEF and FOXA3, was also
unaffected by the inhibitors at baseline
(Figures 4D and 4E). IL-13 stimulation
elevated the level of MUC5AC gene
expression by 3.5-fold and doubled the
number of goblet cells (Figures 4A, 4B, and
4E). Double staining for MUC5AC and a
cell proliferation marker, Ki-67, showed
that IL-13 stimulation caused a significant
increase in goblet cell proliferation
(Figure 4F). We found that 7-day treatment
with the GABAa and GABAb receptor
blockers, either alone or in combination,
prevented the increase in IL-13–induced
mRNA expression of MUC5AC, SPDEF,
and FOXA3 (Figures 4B–4D). In addition,
treatment with a combination of GABAa
and GABAb receptor blockers significantly
reduced goblet cell proliferation in IL-
13–prestimulated ALI cultures to baseline
amounts (Figures 4A and 4F). Compared
with the combination approach, individual
GABA receptor blockers had a smaller
negative effect on goblet cell proliferation
that failed to reach statistical significance
(Figure 4F). Last, GABA receptor blockers
had no general side effects on cell apoptosis
assayed by staining for activated cleaved
caspase 3 (Figure 4G). Notably, IL-13
treatment reduced the percentage of
apoptotic cells in culture (Figure 4G), which
is consistent with a role of IL-13 in promoting
the expression of an antiapoptotic gene,
BCL2, in airway epithelial cells (33). Together,
our findings indicate that GABA signaling
may be required for the maintenance of IL-
13–induced goblet differentiation and mucus
overproduction and thus may serve as a drug
target under the established disease condition.
Discussion
Previous studies in mice demonstrated that
genetic disruption of GABA signaling
prevented mucus overproduction after early-
life allergen exposure. The present study
indicates that the GABAa and GABAb
receptor pathways may serve as an integral,
evolutionarily conserved component of
mucus production in primates. This extends
previous observations in mice in which



















































































































































































































Figure 4. GABA is required for IL-13–induced goblet cell hyperplasia in ALI cultures of NHBE cells. (A) Representative images of double staining for Ki-67
and MUC5AC in Day 21 ALI cultures of NHBE cells with and without the treatment of IL-13 and combined GABAa and GABAb receptor blockers.
Arrowheads mark MUC5AC1Ki-671 cells. The inset shows an enlarged image of double-positive cells in IL-13–treated cultures. (B–D) MUC5AC, SPDEF
(SAM pointed domain-containing Ets transcription factor), and FOXA3 gene expression in Day 21 ALI cultures of NHBE cells under different culture conditions.
(E) Quantification of the percentages of MUC5AC1 goblet cells in Day 21 ALI cultures under different culture conditions. (F) Goblet cell proliferation in Day 21
ALI cultures under different culture conditions. Proliferation was quantified by normalizing the number of MUC5AC1Ki-671 cells to the total MUC5AC1 goblet
cells. More than 500 cells from each donor were counted for each condition. (G) Representative images of staining for cleaved caspase 3 in Day 21 ALI
cultures with and without the treatment of IL-13 and combined GABAa and GABAb receptor blockers. Data in B–D represent mean6 SEM of three
independent experiments in triplicates for each donor, three donors in total. *P, 0.05 and **P, 0.01. Arrowheads mark caspase 31 cells. Scale bars: 50 mm.
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prevented mucus overproduction after early-
life antigen exposure (12). In patients with
asthma, there is elevated expression of three
genes representing both subtypes of GABA
receptors, which suggests aberrant GABA
signaling in airway epithelium. We also
show that GABA is mostly produced by
PNECs through the enzymatic activities of
GAD67 in both nonhuman primates and
humans. In addition, early-life exposure
to environmental insults in nonhuman
primates causes aberrant PNEC innervation
and GABA hypersecretion. The observed
increase in PNEC innervation is aligned
with previous findings that early-life
environmental exposures cause airway
epithelium hyperinnervation in nonhuman
primates (7). Collectively, these findings
suggest that deregulation of the
nerve–PNEC–GABA axis plays an essential
role in both the initiation and the
progression of IL-13–induced mucus
overproduction. If true, GABA secretion and
GABA receptor signaling may serve as valid
drug targets to directly block/reverse mucus
overproduction in patients with asthma who
have higher concentrations of IL-13.
We provide evidence that in the
presence of IL-13, the GABAa and GABAb
receptors play a similar role in MUC5AC
gene expression and synergistically
contribute to goblet cell proliferation. We
speculate that the molecular signaling
mechanism of the GABA pathway in
mucus overproduction may involve
ionotropic and metabotropic receptor
functions. The GABAa receptor is a
chloride channel. GABA binding to the
GABAa receptor triggers an inward
current in cultured airway epithelial
cells by electrophysiological assays.
This finding indicates that GABA is an
excitatory signal (18, 19), which is
different from a predominantly inhibitory
neurotransmitter function of GABA in the
central nervous system. GABA also has
been shown to block apical-to-basolateral
transport of Cl2 in alveolar type II cells
(34). Notably, cystic fibrosis
transmembrane conductance regulator is
also a Cl2 channel. Mutations in cystic
fibrosis transmembrane conductance
regulator cause cystic fibrosis, a lung
disease with clinical features of abnormal
mucus secretion and clearance. Whether
the GABAa receptor contributes to mucus
production and secretion in allergic
inflammation by regulating Cl2 outflux in
airway epithelial cells warrants future
investigation. In addition to ionotropic
GABAa receptors, the GABAb receptor is
a metabotropic, G protein–coupled
receptor that regulates cAMP production,
a secondary messenger that may act
together with IL-13 to regulate MUC5AC
gene expression (35). Interestingly,
GABBR2 is broadly expressed by primary
human airway epithelium cells, and not
all goblet cells express GABBR2. These
findings raise the possibility that the
GABAb pathway may signal directly in
goblet cells and indirectly by acting on
other epithelial cells and triggering
paracrine mechanisms to affect goblet
cells. These possibilities need to be tested
in future studies. It is important to
emphasize that GABA signaling alone has
no effect on mucus production in the
airway. As shown in our previous work
in vivo (12) and this work in vitro, the role
of GABA signaling in mucus overproduction
requires IL-13. It is possible that IL-13 may
compromise the barrier function of airway
epithelium so that basally located GABA can
diffuse to the apical side of epithelial cells to
interact with GABA receptors.
In addition to asthma, mucus
overproduction is a major factor in the
exacerbation of COPD. COPD is strongly
associated with cigarette smoking. Using a
nonhuman primate epithelial cell culture
model, previous studies showed that the
GABAa receptors played an essential role
in nicotine-induced mucus overproduction
without the involvement of IL-13 (20). In
that study, nicotine upregulated GABA
production and GABAa receptor
expression in the airway epithelium to
induce mucus overproduction.
Mechanisms that regulate GABA
receptor expression in the airway epithelium
by nicotine and inflammation warrant future
investigation. In an acute model of allergen
exposure in mice, we found no change in
airway epithelial expression of the GABA
receptors (12). However, three GABA receptor
genes exhibit an increase in expression in
patients with asthma. We speculate that
chronic allergic inflammation may contribute
to the upregulation of GABA receptor gene
expression in patients with asthma.
In summary, our studies have
demonstrated that PNEC-derived GABA
is required for the induction of mucus
overproduction in both rodent and primate
models of asthma (12, 18). GABA signaling
also contributes to nicotine-induced mucus
overproduction, which has implications in
COPD (12, 19, 20). In addition, calcitonin-
related gene peptide secreted by PNECs
promotes inflammation by activating
innate lymphoid cells (14). Furthermore,
PNEC hyperplasia has been associated with
pulmonary disorders in young children and
unusual forms of interstitial lung disease
(36–38). Because PNECs are a critical
source of neuropeptides and bioactive
amines in airway epithelium, it is possible
that aberrant PNEC secretion associated
with PNEC hyperplasia may contribute
to the pathogenesis of these rare diseases.
Our studies show that PNEC secretion
is regulated by a neurocircuitry that
innervates PNECs (12). In this context, the
identification of neural pathways that
regulate PNEC secretion may provide new
drug targets for the treatment of a variety of
lung diseases. n
Author disclosures are available with the text
of this article at www.atsjournals.org.
Acknowledgment: The authors thank the entire
Ai laboratory for critical discussion of the project.
References
1. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J
Med 2010;363:2233–2247.
2. Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev
Med 2002;53:477–498.
3. Stern DA, Morgan WJ, Halonen M, Wright AL, Martinez FD. Wheezing
and bronchial hyper-responsiveness in early childhood as predictors
of newly diagnosed asthma in early adulthood: a longitudinal birth-
cohort study. Lancet 2008;372:1058–1064.
4. Aven L, Paez-Cortez J, Achey R, Krishnan R, Ram-Mohan S,
Cruikshank WW, et al. An NT4/TrkB-dependent increase
in innervation links early-life allergen exposure to
persistent airway hyperreactivity. FASEB J 2014;28:
897–907.
5. Herring MJ, Putney LF, St George JA, Avdalovic MV,
Schelegle ES, Miller LA, et al. Early life exposure to allergen
and ozone results in altered development in adolescent
rhesus macaque lungs. Toxicol Appl Pharmacol 2015;283:
35–41.
ORIGINAL RESEARCH
Barrios, Kho, Aven, et al.: GABA Signaling in IL-13–induced Mucus Hyperplasia 693
 
6. Wu ZX, Hunter DD, Kish VL, Benders KM, Batchelor TP, Dey RD.
Prenatal and early, but not late, postnatal exposure of mice to
sidestream tobacco smoke increases airway hyperresponsiveness
later in life. Environ Health Perspect 2009;117:1434–1440.
7. Larson SD, Schelegle ES, Walby WF, Gershwin LJ, Fanuccihi MV, Evans
MJ, et al. Postnatal remodeling of the neural components of the
epithelial-mesenchymal trophic unit in the proximal airways of infant
rhesus monkeys exposed to ozone and allergen. Toxicol Appl
Pharmacol 2004;194:211–220.
8. Yu M, Zheng X, Peake J, Joad JP, Pinkerton KE. Perinatal environmental
tobacco smoke exposure alters the immune response and airway
innervation in infant primates. J Allergy Clin Immunol 2008;122:
640–647.e1.
9. Wu ZX, Hunter DD, Batchelor TP, Dey RD. Side-stream tobacco smoke-
induced airway hyperresponsiveness in early postnatal period is
involved nerve growth factor. Respir Physiol Neurobiol 2016;223:1–8.
10. Barrios J, Ai X. Neurotrophins in asthma. Curr Allergy Asthma Rep
2018;18:10.
11. Patel KR, Bai Y, Trieu KG, Barrios J, Ai X. Targeting acetylcholine
receptor M3 prevents the progression of airway hyperreactivity in a
mouse model of childhood asthma. FASEB J 2017;31:4335–4346.
12. Barrios J, Patel KR, Aven L, Achey R, Minns MS, Lee Y, et al. Early life
allergen-induced mucus overproduction requires augmented neural
stimulation of pulmonary neuroendocrine cell secretion. FASEB J
2017;31:4117–4128.
13. Schnorbusch K, Lembrechts R, Pintelon I, Timmermans JP, Brouns I,
Adriaensen D. GABAergic signaling in the pulmonary neuroepithelial
body microenvironment: functional imaging in GAD67-GFP mice.
Histochem Cell Biol 2013;140:549–566.
14. Sui P, Wiesner DL, Xu J, Zhang Y, Lee J, Van Dyken S, et al. Pulmonary
neuroendocrine cells amplify allergic asthma responses. Science
2018;360:eaan8546.
15. Evans CM, Williams OW, Tuvim MJ, Nigam R, Mixides GP, Blackburn
MR, et al. Mucin is produced by Clara cells in the proximal airways of
antigen-challenged mice. Am J Respir Cell Mol Biol 2004;31:382–394.
16. Reader JR, Tepper JS, Schelegle ES, Aldrich MC, Putney LF, Pfeiffer
JW, et al. Pathogenesis of mucous cell metaplasia in a murine
asthma model. Am J Pathol 2003;162:2069–2078.
17. Chen G, Korfhagen TR, Xu Y, Kitzmiller J, Wert SE, Maeda Y, et al.
SPDEF is required for mouse pulmonary goblet cell differentiation
and regulates a network of genes associated with mucus production.
J Clin Invest 2009;119:2914–2924.
18. Park SW, Verhaeghe C, Nguyenvu LT, Barbeau R, Eisley CJ, Nakagami
Y, et al. Distinct roles of FOXA2 and FOXA3 in allergic airway disease
and asthma. Am J Respir Crit Care Med 2009;180:603–610.
19. Xiang YY, Wang S, Liu M, Hirota JA, Li J, Ju W, et al. A GABAergic
system in airway epithelium is essential for mucus overproduction in
asthma. Nat Med 2007;13:862–867.
20. Fu XW, Wood K, Spindel ER. Prenatal nicotine exposure increases
GABA signaling and mucin expression in airway epithelium. Am J
Respir Cell Mol Biol 2011;44:222–229.
21. Singh SP, Gundavarapu S, Peña-Philippides JC, Rir-Sima-ah J, Mishra
NC, Wilder JA, et al. Prenatal secondhand cigarette smoke promotes
Th2 polarization and impairs goblet cell differentiation and airway
mucus formation. J Immunol 2011;187:4542–4552.
22. Schelegle ES, Miller LA, Gershwin LJ, Fanucchi MV, Van Winkle LS,
Gerriets JE, et al. Repeated episodes of ozone inhalation amplifies
the effects of allergen sensitization and inhalation on airway immune
and structural development in Rhesus monkeys. Toxicol Appl
Pharmacol 2003;191:74–85.
23. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH,
Donnelly S, et al. Genome-wide profiling identifies epithelial cell
genes associated with asthma and with treatment response to
corticosteroids. Proc Natl Acad Sci USA 2007;104:15858–15863.
24. Storey JD. A direct approach to false discovery rates. J R Stat Soc Ser
A Stat Soc 2002;64:479–498.
25. Fulcher ML, Randell SH. Human nasal and tracheo-bronchial
respiratory epithelial cell culture. Methods Mol Biol 2013;945:
109–121.
26. Park JA, Tschumperlin DJ. Chronic intermittent mechanical stress
increases MUC5AC protein expression. Am J Respir Cell Mol Biol
2009;41:459–466.
27. Linnoila RI. Functional facets of the pulmonary neuroendocrine system.
Lab Invest 2006;86:425–444.
28. Ross AJ, Dailey LA, Brighton LE, Devlin RB. Transcriptional profiling of
mucociliary differentiation in human airway epithelial cells. Am J
Respir Cell Mol Biol 2007;37:169–185.
29. Gu X, Karp PH, Brody SL, Pierce RA, Welsh MJ, Holtzman MJ, et al.
Chemosensory functions for pulmonary neuroendocrine cells. Am J
Respir Cell Mol Biol 2014;50:637–646.
30. Mitchel JA, Antoniak S, Lee JH, Kim SH, McGill M, Kasahara DI, et al.
IL-13 augments compressive stress-induced tissue factor
expression in human airway epithelial cells. Am J Respir Cell Mol Biol
2016;54:524–531.
31. Zhen G, Park SW, Nguyenvu LT, Rodriguez MW, Barbeau R, Paquet
AC, et al. IL-13 and epidermal growth factor receptor have critical but
distinct roles in epithelial cell mucin production. Am J Respir Cell Mol
Biol 2007;36:244–253.
32. Gomperts BN, Kim LJ, Flaherty SA, Hackett BP. IL-13 regulates cilia
loss and foxj1 expression in human airway epithelium. Am J Respir
Cell Mol Biol 2007;37:339–346.
33. Chand HS, Harris JF, Tesfaigzi Y. IL-13 in LPS-induced inflammation
causes Bcl-2 expression to sustain hyperplastic mucous cells. Sci
Rep 2018;8:436.
34. Jin N, Kolliputi N, Gou D, Weng T, Liu L. A novel function of ionotropic
g-aminobutyric acid receptors involving alveolar fluid homeostasis. J
Biol Chem 2006;281:36012–36020.
35. Thai P, Loukoianov A, Wachi S, Wu R. Regulation of airway mucin gene
expression. Annu Rev Physiol 2008;70:405–429.
36. Popler J, Gower WA, Mogayzel PJ Jr, Nogee LM, Langston C, Wilson
AC, et al. Familial neuroendocrine cell hyperplasia of infancy. Pediatr
Pulmonol 2010;45:749–755.
37. Young LR, Brody AS, Inge TH, Acton JD, Bokulic RE, Langston C,
et al. Neuroendocrine cell distribution and frequency distinguish
neuroendocrine cell hyperplasia of infancy from other pulmonary
disorders. Chest 2011;139:1060–1071.
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